Overcoming Resistance
People with metastatic hormone receptor-positive breast cancer are living longer, thanks to new targeted therapies and endocrine therapies that can be prescribed when treatment resistance develops.
Progress Against Cancer
People with metastatic hormone receptor-positive breast cancer are living longer, thanks to new targeted therapies and endocrine therapies that can be prescribed when treatment resistance develops.
Blood tests can guide treatment choices, delivering results in less time than traditional biopsies.
New prostate cancer surgery approach can prevent sexual side effects, and some people with esophageal cancer may be able to avoid surgery.
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel bispecific immunotherapy, and more.
A promising new personalized vaccine headlines several recent breakthroughs that highlight progress in kidney cancer research.
Cooling and compression help manage common side effect of chemotherapy, and deadlines encourage people to complete colorectal cancer screening.
After Craig Schumpert learned he had lung cancer that had spread to his brain, bones, and lymph nodes, he started radiation therapy. His oncologist told him he might be eligible for targeted therapy, but...
Pickleball encourages more activity in cancer survivors, and urine test detects aggressive prostate cancer.
Multiple myeloma can be tricky to treat, but many treatment options exist, and new research is constantly supporting more.
HPV vaccine credited for 80% drop in lesions that can lead to cervical cancer, and FDA approves targeted therapy for esophageal cancer.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now